A Phase 1/2 Study to Evaluate Axatilimab in Participants With Active cGVHD
NCT03604692
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
41
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Graft-versus-host-disease
Interventions
DRUG:
axatilimab
Sponsor
Syndax Pharmaceuticals